MicroDose Infusion restores health by mimicking normal phyiology. Please review our Clinical Trials and Publications
The MicroDose is US FDA cleared. It is also FDA approved in other countries and delivers a unique treatment which mimics the normal stimulation of the human liver to restore metabolic processes which are blunted or missing in diabetes and other diseases of metabolism. MicroDose Infusion has achieved an average 29% improvement in metabolism as published in multi-center clinical trials.
We also provide the treatment protocol developed by physicians and scientists in multiple centers, and train physician, nurses and staff on how to deliver the MicroDose Infusion as developed over the last 4 years. The earliest work started over 20 years ago, and has been changed and refined to become a treatment that can correctly claim it restores health and reverses complications of diabetes.
Clinical Trial shows in hundreds of patients that
93% of MicroDose treated will have:
full reversal of Nuropathy of 47.5% or
significant reversal of 45.5% (see studies)
Also, another way to test nerves:
Never Conduction Velocity Study 65% increase in nerve conduction velocity (amazing increase)
Patients on MicroDose Infusion - studies show reversal of kidney function reverse the progression of diabetic kidney disease. (see studies)
Patients on MicroDose Infusion can avoid amputations and heal long-duration unresponsive open wounds (images on request due to severity of wounds healed)
Patients on MicroDose Infusion achieve a remarkable stabilization and many times reversal of eye disease including proliferative retinopathy.
Cardiovascular Disease has multiple aspects resulting in loss of energy, extra oxygen requirements, and metabolically caused inflammation among other problems. Patients on MicroDose Infusion have greater energy and better health.
Hypertension is a common problem and often exists with other complicaitons. While hypertension is not well understood, patient son MicroDose Infusion reduce their need for medication by approximately 50% using even the unimproved treatment
Patients who have diabetes are much more likely to require hospitaliztion. In a large multi-center study of over 1,500 patients, hospitalization was reduced by over 90% with a similar reduction in Emergency Department (ER) rates, as compared to national average.
Due to the restoration of metabolic rates, many other conditions have been treated. These other conditions have shown similar outcomes and will require additional clinical verification of what anecdotal patients have experienced.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.